The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Defining normoxia, physoxia and hypoxia in tumours—implications for treatment response
Open accessAbstract
Tumour hypoxia is increasingly recognized as a major deleterious factor in cancer therapies, as it compromises treatment and drives malignant progression. This review seeks to clarify the oxygen levels that are pertinent to this issue. It is argued that normoxia (20% oxygen) is an extremely poor comparator for "physoxia", i.e. the much lower levels of oxygen universally found in normal tissues, which averages about 5% oxygen, and ranges from about 3% to 7.4%. Importantly, it should be recognized that the median oxygenation in untreated tumours is significantly much lower, falling between approximately 0.3% and 4.2% oxygen, with most tumours exhibiting median oxygen levels <2%. This is partially dependent on the tissue of origin, and it is notable that many prostate and pancreatic tumours are profoundly hypoxic. In addition, therapy can induce even further, often unrecognized, changes in tumour oxygenation that may vary longitudinally, increasing or decreasing during treatment in ways that are not always predictable. Studies that fail to take cognizance of the actual physiological levels of oxygen in tissues (approximately 5%) and tumours (approximately 1%) may fail to identify the real circumstances driving tumour response to treatment and/or malignant progression. This can be of particular importance in genetic studies in vitro when comparison to human tumours is required.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Reduced oxygen tension activates a conserved hypoxic signaling network centered on hypoxia-inducible factors (HIFs)”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [2]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Nevertheless, both physiological and pathological states can transiently disrupt the equilibrium between oxygen supply and demand, resulting in tissue and cellular hypoxia”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [2]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In liver metastases of colorectal cancer, the median PO2 was 6 mmHg as compared with 30 mmHg in normal liver tissue (20).”
From HIF inhibitor 32-134D eradicates murine hepatocellular carcinoma in combination with anti-PD1 therapy (2022) · cites this paper as [20]
The cited source says what the claim attributes to it.
In the citing paper
“This response features extensive transcriptional reprogramming aimed at preserving cellular integrity under low-oxygen conditions”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Lysyl oxidase is essential for hypoxia-induced metastasis
Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhöfer, N., Kong, C., Le, Q.-T., Chi, J.-T. A., Jeffrey, S. S., & Giaccia, A. J. (2006) · Nature · doi:10.1038/nature04695 · Cited by 1,309
RetractedWarburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Molecular mechanisms and clinical applications of angiogenesis
Carmeliet, P., & Jain, R. K. (2011) · Nature · doi:10.1038/nature10144 · Cited by 5,467
Hypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177
Radiobiology for the Radiologist.
(1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-80-3-438_1 · Cited by 3,498
Targeting hypoxia in cancer therapy
Wilson, W. R., & Hay, M. P. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3064 · Cited by 3,172
Modes of resistance to anti-angiogenic therapy
Bergers, G., & Hanahan, D. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2442 · Cited by 2,953
Exploiting tumour hypoxia in cancer treatment
Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828
Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects
Hockel, M., & Vaupel, P. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.4.266 · Cited by 2,662
Pàez‐Ribes, M., Allen, E., Hudock, J., Takeda, T., Okuyama, H., Viñals, F., Inoue, M., Bergers, G., Hanahan, D., & Casanovas, O. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.027 · Cited by 2,373
Research works printed but not linked: 8
- Vaupel P, 2010, Exp Oncol, 32, 125
- Vaupel P, 2003, Cancer Res, 63, 7634
- Höckel M, 1991, Cancer Res, 51, 6098
- Kallinowski F, 1995, Tumor oxygenation, 291
- Kallinowski F, 1995, Tumor oxygenation, 205
- Vaupel P, 2006, Eur J Gynaecol Oncol, 27, 142
- Stone JE, 2005, Eur J Gynaecol Oncol, 26, 31
- Cairns RA, 2001, Cancer Res, 61, 8903
Cited by
Sorted by citations
Items 501–600 of 1,000
Wik, J. A., Chowdhury, A. I., Kolan, S. S., Bastani, N. E., Li, G., Alam, K., Grimolizzi, F., & Skålhegg, B. S. (2022) · Biochemical Journal · doi:10.1042/bcj20220144 · Cited by 13
Reiterer, M., Eakin, A., Burke, A., Johnson, R. S., & Branco, C. M. (2022) · Cells · doi:10.3390/cells11162469 · Cited by 11
Chakraborty, A., Perez, M., Carroll, J. D., Antonopoulos, A., Dell, A., Ortega, L., Mohammed, N. B. B., Wells, M., Staudinger, C., Griswold, A. J., et al. (2022) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2022.07.033 · Cited by 11
Chee, N. T., Carriere, C. H., Miller, Z., Welford, S. M., & Brothers, S. P. (2022) · Oncology Reports · doi:10.3892/or.2022.8451 · Cited by 11
Progress and challenges in experimental models for pheochromocytoma and paraganglioma
Tischler, A. S., & Favier, J. (2022) · Endocrine Related Cancer · doi:10.1530/erc-22-0405 · Cited by 11
Nanoparticles for Interrogation of Cell Signaling
Lee, S., Jiao, M., Zhang, Z., & Yu, Y. (2023) · Annual Review of Analytical Chemistry · doi:10.1146/annurev-anchem-092822-085852 · Cited by 11
Baltazar, F., Tessonnier, T., Haberer, T., Debus, J., Herfarth, K. K., Tawk, B., Knoll, M., Abdollahi, A., Liermann, J., & Mairani, A. (2023) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2023.109872 · Cited by 10
Exploiting the DNA Damage Response for Prostate Cancer Therapy
Stracker, T. H., Osagie, O. I., Escorcia, F. E., & Citrin, D. E. (2023) · Cancers · doi:10.3390/cancers16010083 · Cited by 12
Lu, Y., Hua, Y., Wang, B., Zhong, F., Theophanous, A., Tahir, S., Lee, P., & Sigal, I. A. (2024) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.65.5.1 · Cited by 11
Investigating Microenvironmental Regulation of Human Chordoma Cell Behaviour
Patel, P., Brooks, C. R., Seneviratne, A. K., Hess, D. A., & Séguin, C. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115909 · Cited by 11
de Padua, M. M. C., Noleto, G. R., Petkowicz, C. L. D. O., Cadena, S. M. S. C., Bost, F., Pouysségur, J., & Mazure, N. M. (2019) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-019-0135-3 · Cited by 11
Setanaxib as a Potent Hypoxia-specific Therapeutic Agent Against Liver Cancer
Owada, S., Endo, H., Okada, C., Yoshida, K., Shida, Y., & Tatemichi, M. (2020) · Anticancer Research · doi:10.21873/anticanres.14510 · Cited by 11
“Hypoxic” Silurian oceans suggest early animals thrived in a low-O2 world
Haxen, E. R., Schovsbo, N. H., Nielsen, A. T., Richoz, S., Loydell, D. K., Posth, N. R., Canfield, D. E., & Hammarlund, E. U. (2023) · Earth and Planetary Science Letters · doi:10.1016/j.epsl.2023.118416 · Cited by 12
Wang, Y., Zhang, R., Chen, Q., Lei, Z., Shi, C., Pang, Y., Zhang, S., He, L., Xu, L., Xing, J., et al. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.98387 · Cited by 10
Bridging the gap: advancing cancer cell culture to reveal key metabolic targets
Kes, M. M. G., Berkers, C. R., & Drost, J. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1480613 · Cited by 9
Luo, W., Chen, G. T. Y., Huang, R., Chen, Y., & Hsiao, Y.-Y. (2019) · International Journal of Radiation Biology · doi:10.1080/09553002.2020.1688883 · Cited by 10
Biodegradable oxygen biosensors via electrospinning
Cybyk, D. B., Reinsch, B. M., Presley, K. F., Schweller, R. M., Tedeschi, A., Burns, T., Chaparro, F. J., Ly, J., Dalton, M. J., Lozano, M. M., et al. (2020) · Medical Devices & Sensors · doi:10.1002/mds3.10149 · Cited by 10
Oxygen in Metabolic Dysfunction and Its Therapeutic Relevance
López-Pascual, A., Trayhurn, P., Martínez, J. A., & González‐Muniesa, P. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7901 · Cited by 14
Mudassar, F., Shen, H. M., Cook, K. M., & Hau, E. K. C. (2022) · Journal of Medical Imaging and Radiation Oncology · doi:10.1111/1754-9485.13416 · Cited by 10
Smith, P. J., McKEOWN, S. R., & Patterson, L. H. (2022) · IUBMB Life · doi:10.1002/iub.2619 · Cited by 11
Self-citationBoniface, C. T., & Spellman, P. T. (2022) · Pathology & Oncology Research · doi:10.3389/pore.2022.1610103 · Cited by 10
Functional Repercussions of Hypoxia-Inducible Factor-2α in Idiopathic Pulmonary Fibrosis
Torres-Soria, A. K., Romero, Y., Balderas-Martínez, Y. I., Velázquez‐Cruz, R., Espíndola, L. M. T., Camarena, Á., Flores‐Soto, E., Solís‐Chagoyán, H., Ruiz, V., Carlos‐Reyes, Á., et al. (2022) · Cells · doi:10.3390/cells11192938 · Cited by 11
Marassi, V., Giordani, S., Kurevija, A., Panetta, E., Roda, B., Zhang, N., Azzolini, A., Dolzani, S., Manko, D., Reschiglian, P., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415971 · Cited by 10
Kenney, R. M., Lee, M. C., Boyce, M. W., Sitte, Z. R., & Lockett, M. R. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.2c05201 · Cited by 10
The unfolding story of dying tumor cells during cancer treatment
He, S., Huang, Q., & Cheng, J. Q. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1073561 · Cited by 10
Hypoxia effects on oncolytic virotherapy in Cancer: Friend or Foe?
Sadri, M., Najafi, A., Rahimi, A. R., Behranvand, N., Kazemi, M. H., Khorramdelazad, H., & Falak, R. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110470 · Cited by 12
Novel Molecular Targets for Immune Surveillance of Hepatocellular Carcinoma
Guerra, P., Martini, A., Pontisso, P., & Angeli, P. (2023) · Cancers · doi:10.3390/cancers15143629 · Cited by 11
Dailey, K. M., Small, J. M., Pullan, J. E., Winfree, S., Vance, K. E., Orr, M., Mallik, S., Bayles, K. W., Hollingsworth, M. A., & Brooks, A. E. (2023) · PLoS ONE · doi:10.1371/journal.pone.0289183 · Cited by 10
Huang, Y., Jin, C., Yu, J., Wang, L., & Lu, W. P. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.103975 · Cited by 10
de Souza, B. T. L., Klosowski, E. M., Mito, M. S., Constantin, R. P., Mantovanelli, G. C., Mewes, J. M., Bizerra, P. F. V., da Silva, F. S. I., Menezes, P. V. M. D. C., Gilglioni, E. H., et al. (2021) · Toxicology · doi:10.1016/j.tox.2021.152766 · Cited by 10
Hirose, S., Tabata, Y., Sone, K., Takahashi, N., Yoshino, D., & Funamoto, K. (2021) · Cell Adhesion & Migration · doi:10.1080/19336918.2021.1978368 · Cited by 12
Hsiao, Y.-Y., Chen, G. T. Y., Chan, C.-C., & Tsai, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111713 · Cited by 10
Mokoala, K. M. G., Lawal, I. O., Maserumule, L. C., Hlongwa, K., Ndlovu, H., Reed, J., Bida, M., Maes, A., de Wiele, C. V., Mahapane, J., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11040962 · Cited by 10
Iron Mobilization from Ferritin in Yeast Cell Lysate and Physiological Implications
Smith, G. L., Srivastava, A. K., Reutovich, A. A., Hunter, N. J., Arosio, P., Melman, A., & Bou-Abdallah, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116100 · Cited by 10
Spinicci, K., Jacquet, P., Powathil, G., & Stéphanou, A. (2022) · Computational and Systems Oncology · doi:10.1002/cso2.1040 · Cited by 10
Modeling Preclinical Cancer Studies under Physioxia to Enhance Clinical Translation
Adebayo, A. K., & Nakshatri, H. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-2311 · Cited by 12
Availability of Ferritin-Bound Iron to Enterobacteriaceae
Gehrer, C. M., Hoffmann, A., Hilbe, R., Grubwieser, P., Mitterstiller, A., Talasz, H., Fang, F. C., Meyron‐Holtz, E. G., Atkinson, S. H., Weiß, G., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113087 · Cited by 9
Ethnic and paleolithic diet: Where do they stand in inflammation alleviation? A discussion
Patel, S. V., & Suleria, H. A. R. (2017) · Journal of Ethnic Foods · doi:10.1016/j.jef.2017.10.004 · Cited by 10
Epithelial-Mesenchymal Transition in Tumor Microenvironment Induced by Hypoxia
Eskiizmir, G., & Özgür, E. (2018) · IntechOpen eBooks · doi:10.5772/intechopen.78717 · Cited by 11
Dynamics of oxygen level-driven regulators in modulating autophagy in colorectal cancer cells
Tam, S. Y., Wu, V., & Law, H. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.07.043 · Cited by 10
Optimization of Nafion Polymer Electrolyte Membrane Design and Microfabrication
Marland, J. R. K., Moore, F., Dunare, C. C., Tsiamis, A., González‐Fernández, E., Blair, E. O., Smith, S., Terry, J. G., Murray, A. F., & Walton, A. J. (2020) · IEEE Transactions on Semiconductor Manufacturing · doi:10.1109/tsm.2020.2983875 · Cited by 10
Analysis of epigenetic aging in vivo and in vitro : Factors controlling the speed and direction
Matsuyama, M., Søraas, A. V. L., Yu, S. G., Kim, K., Stavrou, E. X., Caimi, P. F., Wald, D. N., Lima, M. J. G. D., Dahl, J. A., Horvath, S., et al. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370220947015 · Cited by 11
Bai, Y., Shi, J., Liu, Q., Yang, D., Yan, Z., Zhang, J.-K., Tang, H., Guo, W.-Z., Jin, Y., & Zhang, S. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166686 · Cited by 9
Paun, R. A., Dumut, D. C., Li, L., Radzioch, D., & Tabrizian, M. (2025) · npj Biomedical Innovations. · doi:10.1038/s44385-024-00006-6 · Cited by 9
Fast high-resolution lifetime image reconstruction for positron lifetime tomography
Huang, B., Wang, Z., Zeng, X., Goldan, A. H., & Qi, J. (2025) · Communications Physics · doi:10.1038/s42005-025-02100-6 · Cited by 9
Hyperoxygenation Ameliorates Stress-induced Neuronal and Behavioral Deficits
Choi, J., Kwon, H., Seoh, J., & Han, P. (2021) · Experimental Neurobiology · doi:10.5607/en21029 · Cited by 9
Role of prolyl hydroxylase domain proteins in bone metabolism
Wolf, D., Muralidharan, A., & Mohan, S. (2022) · Osteoporosis and Sarcopenia · doi:10.1016/j.afos.2022.03.001 · Cited by 10
Modeling hypoxia-related inflammation scenarios
Ferrante, P., Preziosi, L., & Scianna, M. (2022) · Mathematical Biosciences · doi:10.1016/j.mbs.2022.108952 · Cited by 9
Sundaresan, A., Ngoc, M. L., Wew, M. U., Ramkumar, V., Raninga, P. V., Sum, R., & Cheong, I. (2023) · Communications Biology · doi:10.1038/s42003-023-04496-9 · Cited by 9
Zhang, R., Yang, A., Zhang, L., He, L., Gu, X., Yu, C., Lu, Z., Wang, C., Zhou, F., Li, F., et al. (2023) · Acta Physiologica · doi:10.1111/apha.14018 · Cited by 9
Mitochondrial Factors in the Cell Nucleus
González‐Arzola, K., & Dı́az-Quintana, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713656 · Cited by 12
Oxygen/Nitric Oxide Dual-Releasing Nanozyme for Augmenting TMZ-Mediated Apoptosis and Necrosis
Ma, J., Qiu, J., Wright, G. A., & Wang, S. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.4c00817 · Cited by 11
Nesbitt, H., Worthington, J., Errington, R. J., Patterson, L. H., Smith, P. J., McKEOWN, S. R., & McKenna, D. J. (2017) · The Prostate · doi:10.1002/pros.23434 · Cited by 9
Self-citationSun, Y., Su, X., Zhou, R., Wang, D., Yuan, Z., Jiang, Y., Wang, L., & Chen, Y. (2018) · Tetrahedron · doi:10.1016/j.tet.2018.08.030 · Cited by 9
Bawab, A. Q. A., Zihlif, M., Jarrar, Y. B., & Sharab, A. (2020) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530320666200506082020 · Cited by 9
Baqlouq, L., Zihlif, M., Hammad, H. M., & Thiab, T. M. A. (2020) · Current Molecular Pharmacology · doi:10.2174/1874467213666200521081653 · Cited by 9
A NIR fluorescent smart probe for imaging tumor hypoxia
Hettie, K. S., Klockow, J., Moon, E. J., Giaccia, A. J., & Chin, F. T. (2021) · Cancer Reports · doi:10.1002/cnr2.1384 · Cited by 9
Jansen, J., Vieten, P., Pagliari, F., Hanley, R., Marafioti, M. G., Tirinato, L., & Seco, J. C. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.597635 · Cited by 9
de Buhr, N., Martens, A., Meurer, M., Bonilla, M. C., Söbbeler, F. J., Twele, L., Neudeck, S., Wendt, M., Beineke, A., Kästner, S., et al. (2021) · BMC Neuroscience · doi:10.1186/s12868-021-00648-x · Cited by 9
Abbattista, M. R., Ashoorzadeh, A., Guise, C. P., Mowday, A. M., Mittra, R., Silva, S., Hicks, K. O., Bull, M. R., Jackson-Patel, V., Lin, X., et al. (2021) · Pharmaceuticals · doi:10.3390/ph14121231 · Cited by 9
Xiong, J., Wang, Y., Jiang, X., Liang, X., & Liang, Q. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.1c04468 · Cited by 9
Duffy, S., & Avery, V. M. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.01282-21 · Cited by 9
DeMichele, E., Sosnowski, O., Buret, A. G., & Allain, T. (2023) · Microorganisms · doi:10.3390/microorganisms11061598 · Cited by 11
Tumor Microenvironment‐Related Sonodynamic Therapy Mediates Tumor Therapy
Wang, X., Wang, C., Tian, H., Wu, B., & Cheng, W. (2023) · Advanced Therapeutics · doi:10.1002/adtp.202300265 · Cited by 9
Hypoxia-Associated Alternative Splicing Signature in Lung Adenocarcinoma
Xu, Z., Wei, J., Qin, F., Sun, Y., Xiang, W., Yuan, L., Qin, J., Deng, K., Zheng, T., & Li, S. (2020) · Epigenomics · doi:10.2217/epi-2020-0399 · Cited by 9
HIF1α: A Novel Biomarker with Potential Prognostic and Immunotherapy in Pan‐cancer
Tian, Y., Bai, F., & Zhang, D. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/1246267 · Cited by 9
Iron, Copper, and Selenium: Cancer's Thing for Redox BlingPreprint
Terzi, E. M., & Possemato, R. (2023) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041545 · Cited by 9
Wang, C., Stöckl, S., Pattappa, G., Schulz, D., Hofmann, K., Ilić, J., Reinders, Y., Bauer, R. J., Sickmann, A., & Grässel, S. (2023) · Biomedicines · doi:10.3390/biomedicines11102804 · Cited by 8
Impact of hypoxia on the molecular content of glioblastoma-derived exosomes
Giulio, S. D., Carata, E., Muci, M., Mariano, S., & Panzarini, E. (2024) · Extracellular Vesicles and Circulating Nucleic Acids · doi:10.20517/evcna.2023.52 · Cited by 10
Seo, D., Huh, Y. H., Cheong, H., Kim, E., Lim, J.-S., Lee, M. J., Lee, D., & Ryu, K. (2024) · JACS Au · doi:10.1021/jacsau.4c00262 · Cited by 8
Pericytes require physiological oxygen tension to maintain phenotypic fidelity
McErlain, T., McCulla, E. C., Glass, M. J., Hillers‐Ziemer, L. E., Branco, C. M., & Murgai, M. (2024) · Scientific Reports · doi:10.1038/s41598-024-80682-x · Cited by 11
Lyubetskaya, A., Rabe, B. A., Kavran, A. J., Bai, Y., Fisher, A., Font‐Tello, A., Lewin, A. C., Pliner, H. A., Fan, Y., Giampapa, L., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2025.116827 · Cited by 10
Su, Q., Wu, Q., Chen, K., Wang, J., Sarwar, A., & Zhang, Y. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06950-5 · Cited by 8
Liu, S., Washio, J., Sato, S., Abiko, Y., Shinohara, Y., Kobayashi, Y., Otani, H., Sasaki, S., Wang, X., & Takahashi, N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020989 · Cited by 8
Mishra, A. K., Singh, S., Dayanandan, S., Banerjee, S., Chakraborty, S., Gopal, A. B., Samal, S., Poirah, I., Chakraborty, D., & Bhattacharyya, A. (2022) · Cytokine · doi:10.1016/j.cyto.2022.155917 · Cited by 8
Noguchi, S., Wakita, K., Matsuda, F., & Shimizu, H. (2022) · Metabolic Engineering · doi:10.1016/j.ymben.2022.07.008 · Cited by 7
Epidermal Growth Factor Receptor Inhibition Is Protective in Hyperoxia‐Induced Lung Injury
Harris, Z. M., Sun, Y. H., JOERNS, J. O., Clark, B., Hu, B., Korde, A., Sharma, L., Shin, H. J., Manning, E. P., Placek, L., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/9518592 · Cited by 9
Mandala, V. K., Bollaboina, S. K. Y., Changala, B., Kotha, R., & Kasula, L. (2023) · Cureus · doi:10.7759/cureus.45561 · Cited by 8
The impact of cycling hypoxia on the phenotype of HPV‐positive cervical cancer cells
Heber, N., Kuhn, B. J., Strobel, T. D., Lohrey, C., Krijgsveld, J., Hoppe‐Seyler, K., & Hoppe‐Seyler, F. (2023) · Journal of Medical Virology · doi:10.1002/jmv.29280 · Cited by 9
Tip of the Iceberg: A New Wave of Iron–Sulfur Cluster Proteins Found in Viruses
Heffner, A. L., & Maio, N. (2024) · Inorganics · doi:10.3390/inorganics12010034 · Cited by 8
Autophagy is the main driver of radioresistance of HNSCC cells in mild hypoxia
Hill, R. M., Li, C., Hughes, J. R., Rocha, S., Grundy, G. J., & Parsons, J. L. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18482 · Cited by 8
Potential role of the glycolytic oscillator in acute hypoxia in tumors
Fru, L. C., Adamson, E. B., Campos, D. D., Fain, S. B., Jacques, S. L., van der Kogel, A. J., Nickel, K. P., Song, C., Kimple, R. J., & Kissick, M. W. (2015) · Physics in Medicine and Biology · doi:10.1088/0031-9155/60/24/9215 · Cited by 8
Zhao, Y., Han, F., Zhang, X., Zhou, C., & Huang, D. (2020) · Oncology Letters · doi:10.3892/ol.2020.11917 · Cited by 8
Biophysical and Epigenetic Regulation of Cancer Stemness, Invasiveness, and Immune Action
Veerasubramanian, P. K., Trinh, A., Akhtar, N., Liu, W. F., & Downing, T. L. (2020) · Current Tissue Microenvironment Reports · doi:10.1007/s43152-020-00021-w · Cited by 8
Sabry, H. S., Tayel, S. I., Enar, M., & Elabd, N. S. (2021) · Clinical and Experimental Hepatology · doi:10.5114/ceh.2021.111060 · Cited by 8
Hypoxia classifier for transcriptome datasets
Puente-Santamaría, L., Sanchez-Gonzalez, L., Ramos, R., & del Peso, L. (2022) · BMC Bioinformatics · doi:10.1186/s12859-022-04741-8 · Cited by 8
Matsuya, Y., McMahon, S. J., Butterworth, K. T., Yachi, Y., Saga, R., Sato, T., & Prise, K. M. (2023) · Physics in Medicine and Biology · doi:10.1088/1361-6560/acc720 · Cited by 8
Schmidt, K., Thatcher, A., Grobe, A. C., Broussard, P., Hicks, L. D., Gu, H., Ellies, L. G., Sears, D. D., Kalachev, L. V., & Kroll, E. (2024) · Translational Medicine Communications · doi:10.1186/s41231-024-00178-8 · Cited by 9
AKT inhibition as a strategy for targeting hypoxic HPV-positive HNSCC
Göttgens, E., Bussink, J., Ansems, M., Hammond, E. M., & Span, P. N. (2020) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2020.04.048 · Cited by 8
Magdaleno, C., Dixon, L., Rajasekaran, N., & Varadaraj, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-75756-5 · Cited by 8
Rapid Evaluation of Novel Therapeutic Strategies Using a 3D Collagen-Based Tissue-Like Model
Maury, P., Porcel, E., Mau, A., Lux, F., Tillement, O., Mahou, P., Schanne‐Klein, M., & Lacombe, S. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.574035 · Cited by 9
de Almeida, A., Parthimos, D., Dew, H., Smart, O. S., Wiltshire, M., & Errington, R. J. (2021) · Cells · doi:10.3390/cells10040838 · Cited by 8
Guan, S., Wu, C., Liao, T.-Z., Lin, K., Peng, C., Shih, Y., Weng, M., Chen, C.-T., Yeh, C., Wang, Y.-C., et al. (2021) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2021.08.004 · Cited by 8
Calpain-2 regulates hypoxia/HIF-induced amoeboid reprogramming and metastasisPreprint
Boekhorst, V. T., Jiang, L., Mählen, M., Meerlo, M., Dunkel, G., Durst, F. C., Yang, Y., Levine, H., Burgering, B. M. T., & Friedl, P. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.01.06.892497 · Cited by 8
Miller, C., Klyuzhin, I. S., Chaussé, G., Brosch-Lenz, J., Koniar, H., Shi, K., Rahmim, A., & Uribe, C. (2024) · EJNMMI Physics · doi:10.1186/s40658-024-00700-9 · Cited by 7
Wang, G., Zhang, L., Tan, J., Li, F., Jin, Y., He, L., & Yang, X. (2025) · Advanced Biology · doi:10.1002/adbi.202400583 · Cited by 7
Acid-Responsive Thiocarbonylated Coumarin Photosensitizer for Hypoxia-Tolerant Photodynamic Therapy
Kim, G., Nguyen, V. K. T., Han, J., Cao, L., Lee, S. G., Tran, D. L., Pham, T. C., & Lee, S. (2025) · ACS Applied Bio Materials · doi:10.1021/acsabm.5c00884 · Cited by 7
Liver microenvironment and therapy resistance in hepatocellular carcinoma
Rahi, K., Hedayati, M., Hendi, Z., Najimi, M., & Vosough, M. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104997 · Cited by 8
Sarpaki, S., Cortezon‐Tamarit, F., Exner, R. M., Song, K., de Aguiar, S. R. M. M., Ge, H., Pourzand, C., Paisey, S. J., Kociok-Köhn, G. I., Dilworth, J. R., et al. (2022) · ACS Omega · doi:10.1021/acsomega.1c07396 · Cited by 7
Phua, T. J. (2023) · Frontiers in Aging · doi:10.3389/fragi.2023.1196648 · Cited by 8
Metadata
- Authors
- McKeown, S. R.
- Affiliations
- University of Ulster (GB)
- Corresponding author
- McKeown, S R
- Venue
- The British Journal of Radiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-03
- Volume
- 87
- Issue
- 1035
- Pages
- 20130676
- ISSN
- 0007-1285 (ISSN-L)
- 1748-880X
- PMC
- PMC4064601
- OpenAlex
- W2018722597
- Cited by
- 1,050
- References
- 126
- Citations by year
- 2026: 84 · 2025: 122 · 2024: 129 · 2023: 139 · 2022: 137 · 2021: 152 · 2020: 107 · 2019: 68 · 2018: 56 · 2017: 33 · 2016: 13 · 2015: 5 · 2014: 4
- FWCI
- 1.82
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- British Journal of Radiology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Physical Sciences › Mathematics › Modeling and Simulation › Mathematical Biology Tumor Growth
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- tumor hypoxia, tumor oxygenation, normoxia, treatment response, prostate cancer, pancreatic cancer, malignant progression
- MeSH terms
- Animals, Hypoxia, Humans, Male, Neoplasms, Oxygen, Cell Hypoxia, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review